4 patients as of June 30th (likely to be more now) and soon to be 15. Plus the sheep data, pig data and further bench data. Plenty of evidence of what the valve is doing and likely to continue to do. It’s results are replicable due to the valve design and how it works.
Can’t wait for the initial results to be presented to the medical community in October.
Changes in label for Medtronic - results compared to AVR, page-4
-
- There are more pages in this discussion • 5 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$11.76 |
Change
-0.390(3.21%) |
Mkt cap ! $248.6M | |||
| Open | High | Low | Value | Volume |
| $12.15 | $12.27 | $11.27 | $382.7K | 32.38K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 420 | $11.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $11.85 | 2000 | 1 |
View Market Depth
| Last trade - 16.10pm 07/10/2024 (20 minute delay) ? |
| AVR (ASX) Chart |